Brown Brothers Harriman & Co’s Guardant Health GH Stock Holding History

Brown Brothers Harriman & Co’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-108	Closed	-$11K	–	1278
2021 Q4	$11K	Hold	108	–	–	﹤0.01%	899
2021 Q3	$14K	Hold	108	–	–	﹤0.01%	860
2021 Q2	$13K	Hold	108	–	–	﹤0.01%	868
2021 Q1	$16K	Hold	108	–	–	﹤0.01%	800
2020 Q4	$14K	Buy	+108	New	+$12.4K	﹤0.01%	825

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Brown Brothers Harriman & Co's GH Position: Q1 2022 in Review

Brown Brothers Harriman & Co sold out of Guardant Health (GH) in Q1 2022, closing a stake of 108 shares — an estimated $11K sold.

Brown Brothers Harriman & Co first reported a position in GH in Q4 2020 and held it in 5 quarters. The position peaked at $16K in Q1 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

Brown Brothers Harriman & Co reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
Brown Brothers Harriman & Co sold 108 Guardant Health shares in Q1 2022, an estimated $11K.
Brown Brothers Harriman & Co first reported a position in Guardant Health in Q4 2020 and held it in 5 quarters.
Brown Brothers Harriman & Co's Guardant Health position peaked at $16K in Q1 2021.
356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2022, filed 13 May 2022.